Zobrazeno 1 - 10
of 150
pro vyhledávání: '"M. Benabbes"'
Autor:
Soumaya El Baraka, Younes Rahali, Joseph Sitsopeh, Mohammed Jaouad Belahcen, M Benabbes, Soumaya Arbai, Jean-Marie Ouedraogo
Publikováno v:
Le Pharmacien Hospitalier et Clinicien. 56:282-290
Summary Objective To show the place and the interest of dose readjustment in the non-administered chemotherapy preparations reallocation process. Materials and method This study is a retrospective study over a 6-month period. The reallocation process
Autor:
Abdelkader Laatiris, Yassir El Alaoui, Aicha Fahri, Younes Rahali, M Benabbes, Naoual Cherkaoui
Publikováno v:
International Journal of Research in Pharmaceutical Sciences. 11:3857-3865
In parenteral nutrition, the lipid emulsions are usually presented separately from other components. The admixture is made just before or during administration because of limited stability. The purpose of the present study is the formulation of lipid
Publikováno v:
Journal of Oncology Pharmacy Practice. 26:1630-1636
Purpose The purpose of this study was to assess the cost saved and the amount of drug wasted when compounding anticancer drugs in the centralized unit for chemotherapy preparation. A secondary objective was to estimate the centralization impact of ac
Publikováno v:
South African Journal of Botany. 123:147-151
Telephium imperati (L) is a Caryophyllaceae species and is traditionally used in Morocco for its wound healing properties. In the present study the aim was to evaluate the wound healing activity of 5% ointment of hydroalcoholic extract of Telephium i
Publikováno v:
Annales Pharmaceutiques Françaises. 75:172-175
A 48-year-old woman developed palmoplantar hyperkeratosis during treatment with imatinib (400mg/day) for treatment of chronic myeloid leukemia. After 5months of treatment, she developed plantar lesions with yellow-brownish plaques and palmar desquama
1ISG-020 Chemical risk assessement in a quality control laboratory by a tool using activity analysis
Publikováno v:
Section 1: Introductory Statements and Governance.
Background Chemical risk is the result of occupational exposure to a chemical agent. This exposure can induce several effects that can cause fatal intoxications. Purpose The purpose is to assess the risks related to the chemical reagents used in the
Publikováno v:
Section 3: Production and Compounding.
Background The lack of quality control of cytotoxic preparations can reduce the security of the chemotherapy circuit. In fact, an overdose may result in serious side effects at the expense of treatment efficiency. On the other hand, a sub-dosage can
Publikováno v:
Section 3: Production and Compounding.
Background Cross-contamination of hospital preparations is one of the most frequent problems in hospitals. It is responsible for quality defects of the drug and the consequences can be very serious. The failure mode and effects criticality analysis (
Publikováno v:
Section 3: Production and Compounding.
Background Emulsions form the basis of a wide range of manufactured products in the pharmaceutical domain. They are constituted by at least two non-miscible liquids. However, instability is the major inconvenience of these galenic forms. Purpose Para
Autor:
M Draoui, M. O. B. Idrissi, A Zahidi, Brahim Mojemmi, S Bennis, A Cheikh, A Nshimirimana, M Alami Chentoufi, Mustapha Bouatia, M Benabbes
Publikováno v:
Eur J Hosp Pharm
Background Iron is used like a medicine to treat or prevent haemolytic anaemia. When iron is administered concomitantly with certain drugs, it can change absorption of these drugs by complex reaction. Consequently, treatments become ineffective. Purp
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d6a2a833e519c0b4f46e779d43d6ba1d
https://europepmc.org/articles/PMC7539394/
https://europepmc.org/articles/PMC7539394/